ADA A1C testing continues to evolve as the 83rd ADA 2023 Scientific Sessions took place June 23–26 in San Diego, California. Cutting-edge research, treatment recommendations, and medical advancements in diabetes care were highlighted at this premier global conference. Leading scientists, healthcare industry leaders, and physicians gathered to gain insights and explore the future of diabetes management.
Among the featured innovators was Orange Biomed. Our team hosted a poster presentation at the diabetes conference (Poster 954-P) within Category 13-B: New Technology—Glucose Monitoring and Sensing.
On Saturday from 11:30 AM to 12:30 PM, company leadership also hosted a Q&A session to discuss our latest diabetes research and novel methodology with conference attendees.
Read more about our ADA A1C testing presentation below.
Presentation Sneak Peek — Revolutionary New Method of A1C Testing at ADA
Orange Biomed has developed the world’s first glycated hemoglobin analyzer based on single-cell analysis of red blood cells: OBM rapid A1c.
The new method leverages microfluidic technology the size of red blood cells, enabling highly-accurate results from one drop of blood.
Our healthcare innovation offers several advantages over existing methods,
- Hospitals can achieve a similar level of accuracy at 1/500th the cost (anticipated) of HPLC equipment.
- Requires 100x less blood than other A1c tests on the market, promoting safety and simplicity of blood draw.
- Measurement is unaffected by hemoglobin variant interference, guaranteeing true accuracy for all patient populations.
Orange Biomed aims to advance diabetes care by providing more accessible and reliable diagnostic tools for both patients and providers, helping reduce the global diabetes burden. We are currently seeking U.S.-based research partners as we work toward anticipated FDA clearance.
If you are interested in learning more or would like to schedule a meeting around the ADA conference, please reach out to our team.
You can also explore our MIT Technology Review interview to learn more about Orange Biomed’s innovative diabetes technology.
We Were There –
Diabetes Technology Meeting
We proudly attended the Diabetes Technology Meeting 2024 from October 15-17 in Burlingame, CA. During the event, we showcased our OBM rapid A1c system at the Startup Showcase and shared insights on advancing equitable diabetes care. It was a fantastic opportunity to connect, learn, and present innovative solutions for better diagnostics.
Discover more about our participation and insights from the event by visiting our dedicated DTM event page.
